Table of Contents 2
Introduction 5
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Overview 6
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Therapeutics Development 7
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Therapeutics Assessment 21
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Companies Involved in Therapeutics Development 29
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Drug Profiles 48
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Dormant Projects 174
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Discontinued Products 179
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Product Development Milestones 180
Appendix 192

List of Tables
Number of Products under Development for Clostridium difficile Infections (Clostridium difficile Associated Disease), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Absynth Biologics Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Actelion Pharmaceuticals Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Akthelia Pharmaceuticals Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Appili Therapeutics Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Assembly Biosciences Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by CaroGen Corp, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Chain Biotechnology Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Crestone Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Daiichi Sankyo Co Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Evec Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Ferring International Center SA, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by ImmuneBiotech AB, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by ImmunoBiology Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Immuron Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Inovio Pharmaceuticals Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Inspyr Therapeutics Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Integrated BioTherapeutics Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Merck & Co Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by MGB Biopharma Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Micropharm Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Miyarisan Pharmaceutical Company Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Nabriva Therapeutics plc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Novabiotics Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by NovoBiotic Pharmaceuticals LLC, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Oragenics Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Otsuka Holdings Co Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Pfizer Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Prokarium Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Sanofi, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Second Genome Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Seres Therapeutics Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Serometrix LLC, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Sorrento Therapeutics Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Summit Therapeutics Plc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Synthetic Biologics Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Valevia UK Ltd, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Valneva SE, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by Vitality Biopharma Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline by XBiotech Inc, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Dormant Projects, H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Dormant Projects, H1 2018 (Contd..1), H1 2018
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Dormant Projects, H1 2018 (Contd..2), H1 2018

List of Figures
Number of Products under Development for Clostridium difficile Infections (Clostridium difficile Associated Disease), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Top 10 Molecule Types, H1 2018
Number of Products by Stage and Top 10 Molecule Types, H1 2018

Companies Mentioned
• Absynth Biologics Ltd
• Actelion Pharmaceuticals Ltd
• Akthelia Pharmaceuticals Ltd
• Appili Therapeutics Inc
• Assembly Biosciences Inc
• CaroGen Corp
• Chain Biotechnology Ltd
• Crestone Inc
• Daiichi Sankyo Co Ltd
• Evec Inc
• Ferring International Center SA
• ImmuneBiotech AB
• ImmunoBiology Ltd
• Immuron Ltd
• Inovio Pharmaceuticals Inc
• Inspyr Therapeutics Inc
• Integrated BioTherapeutics Inc
• Merck & Co Inc
• MGB Biopharma Ltd
• Micropharm Ltd
• Miyarisan Pharmaceutical Company Ltd
• Nabriva Therapeutics plc
• Novabiotics Ltd
• NovoBiotic Pharmaceuticals LLC
• Oragenics Inc
• Otsuka Holdings Co Ltd
• Pfizer Inc
• Prokarium Ltd
• Sanofi
• Second Genome Inc
• Seres Therapeutics Inc
• Serometrix LLC
• Sorrento Therapeutics Inc
• Summit Therapeutics Plc
• Synthetic Biologics Inc
• Valevia UK Ltd
• Valneva SE
• Vitality Biopharma Inc
• XBiotech Inc